Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 515 across all filing types
Latest filing 2025-01-27 Report Publication Anno…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Terminy przekazywania raportów okresowych w 2025 r. - Content (PL)
Report Publication Announcement Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') is announcing the schedule ('terminy przekazywania') for the release of periodic reports (quarterly, semi-annual, and annual reports) for the year 2025. This is an announcement about the timing of future reports, not the reports themselves. Based on the definitions, this fits best under 'Report Publication Announcement' (RPA), which covers announcements regarding the timing or release of company reports. The document length is very short (991 chars), supporting the RPA classification over the full report types (like 10-K or IR).
2025-01-27 Polish
Warunkowa rejestracja akcji serii L oraz M w KDPW - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document text is very short (1175 characters) and announces an action taken by the National Securities Depository (KDPW) regarding the registration of new series of shares (Series L and M) of the Issuer, contingent upon their admission to trading on a regulated market. It cites the legal basis as the Regulation of the Minister of Finance concerning current and periodic information provided by issuers of securities. This is a specific regulatory announcement concerning capital structure changes (new shares being registered for trading) but is not the full report itself. Since it details the registration/issuance of new shares, the most appropriate specific category is 'Share Issue/Capital Change' (SHA). It is not a general 'Regulatory Filing' (RNS) because SHA is more specific to the content.
2025-01-24 Polish
Zmiana zawiadomienia z art. 69 Ustawu o Ofercie złożonego przez Pana Michała Lacha
Major Shareholding Notification Classification · 99% confidence The document is titled "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 ustawy o ofercie (wypełnia akcjonariusz)" which translates to "Notification pursuant to Art. 69 sec. 1 or 2 of the Public Offering Act (completed by the shareholder)". This Polish regulation (Ustawa o ofercie publicznej) mandates notifications regarding changes in significant shareholdings. The content details changes in the shareholding percentage (e.g., 0.87% and 5.6%) of an individual (Michał Lach) in PURE BIOLOGICS S.A. This directly corresponds to the definition of a Major Shareholding Notification, which in our schema is coded as MRQ (Major Shareholding Notification). Although the document is a formal regulatory filing, MRQ is the most specific category for insider/major shareholder transaction disclosures.
2025-01-17 Polish
Korekta zawiadomienia o zmianie stanu posiadania akcji Spółki - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (651 characters) and explicitly states that the content of a correction notice regarding a change in shareholding ('korektę zawiadomienia o zmianie stanu posiadania akcji') is provided in the attachment to the current report ('Treść otrzymanej korekty zawiadomienia Spółka przekazuje w załączniku do niniejszego raportu bieżącego.'). This structure—a brief announcement pointing to an attachment—strongly suggests a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), rather than the detailed report itself. Since the content relates to a change in significant share ownership (Art. 69 of the Polish Public Offering Act), it is related to Major Shareholding Notification (MRQ). However, because this specific document is merely announcing the publication of the *correction* to that notification, and given the 'MENU VS MEAL' rule, RPA is a strong candidate. Since the core subject is a change in significant shareholding, and MRQ is the specific category for such changes, but this is an announcement of the filing, I must choose between RPA and MRQ. Given the context of regulatory filings in Poland (Raport Bieżący), and the nature of announcing a correction to a prior filing, RNS (Regulatory Filings - the fallback for miscellaneous regulatory announcements) is often used when the specific content type (like MRQ) is not the primary focus of the announcement itself, or if the announcement is simply transmitting the required regulatory document. However, the content is directly about a change in shareholding, which aligns best with MRQ if the content were present. Since this is an announcement of the *publication* of the correction, RPA is the most accurate fit based on the provided definitions for short announcement documents pointing to attachments. If RNS is used as a general regulatory announcement fallback, it also fits. Given the specific nature of the underlying event (shareholding change), and the announcement structure, I will classify it as RNS as it is a general regulatory announcement transmitting required information, which is a common use case for RNS when RPA isn't explicitly about a major report release like an Annual Report.
2025-01-17 Polish
Zawiadomienie z art. 69 Ustawy o Ofercie_Michał Lach
Major Shareholding Notification Classification · 99% confidence The document is titled "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 ustawy o ofercie (wypełnia akcjonariusz)" which translates to a notification based on Article 69, paragraphs 1 or 2 of the Public Offering Act. This type of filing in Polish regulatory context typically concerns changes in significant shareholdings by an individual or entity, often crossing specific ownership thresholds. The content details the change in shareholding for an individual ("Lach Michał") from 0 to 222,222 shares, resulting in a 5.6% stake. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels (crossing thresholds). Although the document is in Polish, the function aligns perfectly with MRQ.
2025-01-16 Polish
Zawiadomienie o zmianie stanu posiadania akcji Spółki - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (575 characters) and explicitly states that the content of a notification received from Mr. Michał Lach regarding a change in shareholding (pursuant to Article 69 of the Public Offering Act) is provided in the attachment to this current report. This structure—announcing receipt of information and referring to an attachment—is characteristic of a regulatory disclosure. Since the content concerns a change in significant share ownership, the most specific category is Major Shareholding Notification (MRQ). However, the text itself is an announcement *about* the notification, not the notification itself, and it uses the generic term 'raport bieżący' (current report). Given the specific nature of the content (change in shareholding), MRQ is the best fit, although RPA or RNS could also be considered if the content was purely administrative. Since the core subject is a change in ownership threshold, MRQ is selected.
2025-01-16 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.